SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MRK: Merck & Co., Inc.
MRK 85.98-0.3%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: wellsaid2/17/2005 1:02:25 PM
   of 22
 
Just read an interesting survey from ChangeWave. They survey industry professionals to detect market trends. 20% of medical professionals surveyed say Cox-II problems will permanently impair Merck’s reputation, and 12% say it will act to limit future market acceptance for Merck drugs
In comparison, only 6% say Pfizer’s reputation will be permanently impaired, and 6% say it will act to limit future market acceptance for Pfizer drugs. Any thoughts?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext